2016
DOI: 10.1007/s11164-016-2592-x
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, anti-hyperglycaemic activity, and in-silico studies of N-substituted 5-(furan-2-ylmethylene)thiazolidine-2,4-dione derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…For example, by reacting thiazolidine-2,4-diones with furan-2-carbaldehyde and alkyl halides, a series of N-substituted 5-(furan-2-ylmethylene)thiazolidine-2,4diones was prepared, that have antihyperglycemic activity. 17 From a synthetic chemistry point of view, the 4-oxo-3aryl/alkyl-2-(arylimino)thiazolidin-5-ylidene moiety has three electrophilic sites, of which the exocyclic C=C double bond acts as a dipolarophile in 1,3-dipolar cycloaddition reactions. Accordingly, Singh and co-workers reported a multicomponent 1,3-dipolar cycloaddition reaction for the synthesis of dispiro-thiazolidinoneoxindoles using (2Z)-methyl-2-((Z)-4-oxo-3-aryl-2-(arylimino)thiazolidin-5ylidene)acetates, substituted isatins and an -amino acid.…”
Section: Paper Synthesismentioning
confidence: 99%
“…For example, by reacting thiazolidine-2,4-diones with furan-2-carbaldehyde and alkyl halides, a series of N-substituted 5-(furan-2-ylmethylene)thiazolidine-2,4diones was prepared, that have antihyperglycemic activity. 17 From a synthetic chemistry point of view, the 4-oxo-3aryl/alkyl-2-(arylimino)thiazolidin-5-ylidene moiety has three electrophilic sites, of which the exocyclic C=C double bond acts as a dipolarophile in 1,3-dipolar cycloaddition reactions. Accordingly, Singh and co-workers reported a multicomponent 1,3-dipolar cycloaddition reaction for the synthesis of dispiro-thiazolidinoneoxindoles using (2Z)-methyl-2-((Z)-4-oxo-3-aryl-2-(arylimino)thiazolidin-5ylidene)acetates, substituted isatins and an -amino acid.…”
Section: Paper Synthesismentioning
confidence: 99%
“…10,11 Reports of anti-hyperglycaemic potential of various 5-arylidene TZD derivatives have been published from various laboratories. 10,[12][13][14][15][16][17][18] Various TZD containing PTP 1B inhibitors incorporated with weakly polar sulfonyl moiety (hydrogen bond acceptor) have revealed interactions with many binding site residues (Ala 217, Ile 221, Gln 262, Arg 254, Tyr 20, Arg 24, Arg 47, Asp 48 and Phe 182) of both catalytic as well as non-catalytic sites of PTP 1B enzyme. [19][20][21][22] Many substituted TZD derivatives have also been reported as aldose reductase inhibitors which have potential to treat type 2 diabetes and the related secondary complications.…”
Section: Introductionmentioning
confidence: 99%